ATE76753T1 - Pharmazeutische zusammensetzung zur intranasalen verabreichung, die ghrh, einen cholinergischen agonisten und gegebenenfalls ein gallensalz enthaelt. - Google Patents
Pharmazeutische zusammensetzung zur intranasalen verabreichung, die ghrh, einen cholinergischen agonisten und gegebenenfalls ein gallensalz enthaelt.Info
- Publication number
- ATE76753T1 ATE76753T1 AT88111657T AT88111657T ATE76753T1 AT E76753 T1 ATE76753 T1 AT E76753T1 AT 88111657 T AT88111657 T AT 88111657T AT 88111657 T AT88111657 T AT 88111657T AT E76753 T1 ATE76753 T1 AT E76753T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- intranasal administration
- optionally
- bile salt
- cholinergic agonist
- Prior art date
Links
- 102100022831 Somatoliberin Human genes 0.000 title abstract 2
- 101710142969 Somatoliberin Proteins 0.000 title abstract 2
- 239000003833 bile salt Substances 0.000 title abstract 2
- 239000000064 cholinergic agonist Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037824 growth disorder Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21513/87A IT1222395B (it) | 1987-07-30 | 1987-07-30 | Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare |
| EP88111657A EP0301392B1 (en) | 1987-07-30 | 1988-07-20 | Pharmaceutical composition for intranasal administration comprising gh - releasing hormone, a cholinergic agonist and in case a bile salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE76753T1 true ATE76753T1 (de) | 1992-06-15 |
Family
ID=11182925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88111657T ATE76753T1 (de) | 1987-07-30 | 1988-07-20 | Pharmazeutische zusammensetzung zur intranasalen verabreichung, die ghrh, einen cholinergischen agonisten und gegebenenfalls ein gallensalz enthaelt. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5010056A (de) |
| EP (1) | EP0301392B1 (de) |
| JP (1) | JPS6450823A (de) |
| KR (1) | KR890001584A (de) |
| AT (1) | ATE76753T1 (de) |
| AU (1) | AU618547B2 (de) |
| DK (1) | DK393188A (de) |
| IT (1) | IT1222395B (de) |
| NO (1) | NO883200L (de) |
| NZ (1) | NZ225546A (de) |
| PH (1) | PH26712A (de) |
| ZA (1) | ZA885417B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0383931A (ja) * | 1989-08-29 | 1991-04-09 | Sumitomo Pharmaceut Co Ltd | 低刺激性ｇｒｆ経鼻投与製剤 |
| EP0432431B1 (de) * | 1989-11-16 | 1993-06-16 | PHIDEA S.p.A. | Flüssige Arzneimittel zur nasalen Anwendung, die ein Polypeptid als Wirksubstanz enthalten |
| US5502067A (en) * | 1994-02-04 | 1996-03-26 | Morgan; Julia A. | Treating apneahypopnea/snoring in humans |
| US5500205A (en) * | 1994-02-23 | 1996-03-19 | Enviro Pac International, L.I.C. | Lachrymator aerosol formulations |
| US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
| AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
| US8048875B1 (en) | 1997-02-24 | 2011-11-01 | S.L.A. Pharma Ag | Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker |
| DK0969813T3 (da) * | 1997-02-24 | 2005-01-31 | Sla Pharma Ag | Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel |
| PT1169065E (pt) * | 1999-04-21 | 2005-07-29 | 1357784 Ontario Inc | Formulacoes para detectar de asma |
| WO2000074652A1 (de) * | 1999-06-02 | 2000-12-14 | Hexal Ag | Pharmazeutische zusammensetzung zur nasalen anwendung von wasserlöslichen wirkstoffen |
| WO2001041732A1 (en) * | 1999-12-06 | 2001-06-14 | Gore Stanley L | Compositions and methods for intranasal delivery of active agents to the brain |
| JP3498041B2 (ja) | 2000-05-29 | 2004-02-16 | 科研製薬株式会社 | プラルモレリン含有点鼻用製剤 |
| US8299079B2 (en) * | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| US20100298335A1 (en) * | 2009-05-22 | 2010-11-25 | Kaufman Herbert E | Preparations and Methods for Ameliorating or Reducing Presbyopia |
| US9540415B2 (en) * | 2013-08-01 | 2017-01-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Inhibitors of the farnesoid X receptor and uses in medicine |
| AU2021334325A1 (en) * | 2020-08-26 | 2023-03-02 | Oticara, Inc. | Compositions devices and methods for treating nasal, otic and other tissue infection and/or inflammation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0625068B2 (ja) * | 1982-12-10 | 1994-04-06 | シンテツクス（ユ−・エス・エ−・）インコ−ポレイテイド | 鼻腔内投与用組成物及びその製造方法 |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| IT1169873B (it) * | 1983-10-21 | 1987-06-03 | Prodotti Formenti Srl | Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica |
| US4818531A (en) * | 1985-02-06 | 1989-04-04 | Eli Lilly And Company | Growth hormone and thyroid hormone |
| JPS62126135A (ja) * | 1985-11-25 | 1987-06-08 | Sumitomo Pharmaceut Co Ltd | 経鼻投与用ｇｒｆ製剤 |
| US4663318A (en) * | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
-
1987
- 1987-07-30 IT IT21513/87A patent/IT1222395B/it active
-
1988
- 1988-07-14 DK DK393188A patent/DK393188A/da not_active Application Discontinuation
- 1988-07-19 NO NO88883200A patent/NO883200L/no unknown
- 1988-07-20 AT AT88111657T patent/ATE76753T1/de active
- 1988-07-20 EP EP88111657A patent/EP0301392B1/en not_active Expired - Lifetime
- 1988-07-21 PH PH37251A patent/PH26712A/en unknown
- 1988-07-25 US US07/223,378 patent/US5010056A/en not_active Expired - Fee Related
- 1988-07-25 NZ NZ225546A patent/NZ225546A/en unknown
- 1988-07-25 ZA ZA885417A patent/ZA885417B/xx unknown
- 1988-07-26 AU AU20051/88A patent/AU618547B2/en not_active Ceased
- 1988-07-27 KR KR1019880009436A patent/KR890001584A/ko not_active Withdrawn
- 1988-07-28 JP JP63187052A patent/JPS6450823A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6450823A (en) | 1989-02-27 |
| ZA885417B (en) | 1989-06-28 |
| PH26712A (en) | 1992-09-15 |
| EP0301392B1 (en) | 1992-06-03 |
| NZ225546A (en) | 1990-12-21 |
| DK393188A (da) | 1989-01-31 |
| KR890001584A (ko) | 1989-03-27 |
| DK393188D0 (da) | 1988-07-14 |
| AU618547B2 (en) | 1992-01-02 |
| IT1222395B (it) | 1990-09-05 |
| EP0301392A1 (de) | 1989-02-01 |
| AU2005188A (en) | 1989-02-02 |
| IT8721513A0 (it) | 1987-07-30 |
| US5010056A (en) | 1991-04-23 |
| NO883200L (no) | 1989-01-31 |
| NO883200D0 (no) | 1988-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE76753T1 (de) | Pharmazeutische zusammensetzung zur intranasalen verabreichung, die ghrh, einen cholinergischen agonisten und gegebenenfalls ein gallensalz enthaelt. | |
| DE59009462D1 (de) | Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper. | |
| ES2097155T3 (es) | Forma de dosificacion efervescente y metodo de administracion. | |
| SG52690A1 (en) | Process for the production of biologically active protein (e.g. tgf) | |
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| EP0379806A3 (de) | Pyrimidine und deren pharmazeutisch brauchbare Salze und deren Verwendung als Arzneimittel | |
| DE68923819D1 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
| MY128809A (en) | Pharmaceutical formulation of omeprazole | |
| DE69113470D1 (de) | Intraokulares und intraorbitales Implantat zur kontrollierten Zuführung von Arzneimitteln. | |
| MY103352A (en) | Piperazinyl-heterocyclic compounds | |
| ATE84215T1 (de) | Arzneizubereitung zur oralen anwendung. | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE398618T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten | |
| ATE131050T1 (de) | Matrixtablette zur verlängerten indapamidfreisetzung nach oraler gabe. | |
| ATE94069T1 (de) | Verwendung von physiologisch wirksamen substanzen zur herstellung von medikamenten fuer gehirn- und nervenerkrankungen. | |
| DE3680578D1 (de) | Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung. | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| DE69232016D1 (de) | Pharmazeutische zusammensetzung, die gamma-hydroxybuttersäure oder das entsprechende lakton enthält, zur behandlung von drogenabhängigkeit und ernährungsstörungen | |
| FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| DK325289A (da) | Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet | |
| ES2043736T3 (es) | Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios. | |
| DE60024969D1 (de) | 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| HU9202229D0 (en) | Method for manufacturing new pharmaceutical preparatives containing 2-oxo-benzimidaazoline-1-carboxylic acid derivatives |